Monsanto rejected Bayer’s $62 billion takeover offer, saying the biotech seed giant’s business merited a higher price, though Monsanto said it remains open to further talks on a deal.
Coca-Cola shook up its management, replacing the heads of its Asia and Africa businesses
The core businesses of the mortgage-finance companies are remarkably healthy. But a mix of accounting and politics could cause one or both to need another taxpayer bailout.
Executives can make their mark by becoming CEO of a company owned by private-equity investors. But senior managers risk career derailment if they can’t handle the strict personal accountability often demanded.
The threat of big settlements in Libor litigation may weigh on the earnings of J.P. Morgan, Citigroup and Bank of America.
Future iPhone models may use OLED displays, which would boost demand for Applied Materials’ manufacturing tools.
Even in an Amazon world, Williams-Sonoma, a beaten-down retail stock, could be due for a revival.
Anthem’s deal for Cigna hinges more on antitrust concerns than on infighting.
These reasons mean a shocking first quarter should give way to a less bad year overall.
European equities are clearly unloved. Investors are right to be skeptical, but there may be glimmers of hope.